Interacting Drugs |
Tinzaparin vs Drotrecogin Alfa |
Security Level |
 |
Mechanism |
Drotrecogin Alfa: Heparin (Low Molecular Weight) may enhance the adverse/toxic effect of Drotrecogin Alfa. Bleeding may occur. |
Management |
Potential benefits of therapeutic doses of LMW heparins should be weighed against an increased risk of bleeding in patients who receive drotrecogin alfa. In patients receiving prophylactic LMW heparin doses consider continuing this during drotrecogin. |
Tinzaparin vs Drotrecogin Alfa
Post Review about Tinzaparin vs Drotrecogin Alfa Click here to cancel reply.
Other Interactions of Drotrecogin Alfa
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.